Genicular nerve block provides short-term pain relief in knee osteoarthritis: Study

Written By :  Dr. Kamal Kant Kohli
Published On 2022-11-23 03:30 GMT   |   Update On 2022-11-23 09:43 GMT

Australia: A recent study published in Wiley's Arthritis & Rheumatology has shown that ultrasound-guided genicular nerve block (GNB) provides short-term pain relief in patients with knee osteoarthritis.Results from the clinical trial found that patients with knee osteoarthritis experience short-term pain relief from genicular nerve blocks or locally injected anaesthetics that block...

Login or Register to read the full article

Australia: A recent study published in Wiley's Arthritis & Rheumatology has shown that ultrasound-guided genicular nerve block (GNB) provides short-term pain relief in patients with knee osteoarthritis.

Results from the clinical trial found that patients with knee osteoarthritis experience short-term pain relief from genicular nerve blocks or locally injected anaesthetics that block nerves around the knee joint.

In the parallel-group, placebo-controlled randomized trial of GNB conducted for 12 weeks, 59 patients were randomized to receive a nerve block or a placebo injection. At baseline and weeks 2, 4, 8 and 12, participants recorded their pain on a scale of 0 to 10.

Patients who received a nerve block reported improvement in pain scores at 2, 4, 8 and 12 weeks, compared with baseline, but with diminishing effects over time. Scores for nerve block versus placebo at baseline, weeks 2, 4, 8 and 12 were: 6.2 versus 5.3, 2.7 versus 4.7, 3.2 versus 5.1, 3.9 versus 4.9, and 4.6 versus 5.1, respectively. Most patients who received the blocks felt they had improved or greatly improved from baseline during the follow up period. 

Key findings of the study are listed below:
· 59 patients (36 female, 23 male) who completed the trial had a mean ± SD age of 68.2 ± 8.6 years.
· Patients in the active group reported improvements in pain scores at 2, 4, 8, and 12 weeks with a diminution of the effect over time.
· VAS scores at baseline and at weeks 2, 4, 8, and 12 in the active group (n = 31) versus placebo group (n = 28) were 6.2 versus 5.3, 2.7 versus 4.7, 3.2 versus 5.1, 3.9 versus 4.9, and 4.6 versus 5.1, respectively.
· Total WOMAC scores at baseline and at weeks 2, 4, 6, 8, and 12 in the active group versus the placebo group were 54.5 versus 48.1, 32.9 versus 44.4, 33.7 versus 45.8, 39.2 versus 44.8, and 42.65 versus 45.1, respectively.

"This study demonstrates that genicular nerve block is an effective short-term therapy for pain management in people with knee osteoarthritis," said corresponding author Ernst M. Shanahan, BMBS, MPH, MHPE, PhD, FAFOEM, FRACP, of Flinders University, in Australia. "We think it may be a useful treatment option for this group of people, in particular those waiting for, or wishing to defer surgery."

Reference:

Ernst M. Shanahan,Lucinda Robinson,Suellen Lyne,Richard Woodman,Fin Cai,Kokum Dissanayake,Kate Paddick,Giovanna Cheung,Frank Voyvodic First published: 11 November 2022 https://doi.org/10.1002/art.42384

Tags:    
Article Source : Arthritis & Rheumatology

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News